Sponsored by:

Duke MMIL designs novel SPECT/CT system for 3D breast imaging

Jul 17, 2007
2007 07 17 14 38 39 706
2007 07 17 14 38 39 706
Image courtesy of Duke University Medical Center Multi-Modality Imaging Lab.

close

Latest in Molecular Imaging
Andrew Trout, MD
Andrew Trout tapped to lead radiology at Cincinnati Children's
October 17, 2025
Expand your field of view with new Biograph Trinion.X PET/CT
Sponsored
Expand your field of view with new Biograph Trinion.X PET/CT
October 6, 2025
Business Man Handshake 400
Clarity, Nusano ink Cu-67 supply agreement
October 16, 2025
Atom Nuclear Lab 400
Nusano, Ariceum Therapeutics sign multi-isotope supply agreement
October 14, 2025
Related Stories
2007 07 17 15 08 50 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 07 17 14 32 28 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 06 25 10 54 15 706
Molecular Imaging
Studies link Alzheimer's to beta-amyloid and potential for new ligand
Expand your field of view with new Biograph Trinion.X PET/CT
Sponsor Content
Expand your field of view with new Biograph Trinion.X PET/CT
More in Molecular Imaging
Andrew Trout tapped to lead radiology at Cincinnati Children's
By AuntMinnie.com staff writers
Trout served as director of nuclear medicine at Cincinnati Children’s from 2016 through 2024.
October 17, 2025
Andrew Trout, MD
PET/CT reveals ‘chemo brain’ regions in leukemia patients
By Will Morton
Chemotherapy is associated with brain metabolic alterations, particularly in areas governing cognition and emotion.
October 16, 2025
2025 10 16 Chemo Brain Thumbnail
Clarity, Nusano ink Cu-67 supply agreement
By AuntMinnie.com staff writers
Copper-67 (Cu-67) will be produced at Nusano's Utah-based production facility, which will open in late 2025.
October 16, 2025
Business Man Handshake 400
Nusano, Ariceum Therapeutics sign multi-isotope supply agreement
By AuntMinnie.com staff writers
The agreement will give Ariceum access to Nusano-produced radioisotopes for its novel radiotherapeutics.
October 14, 2025
Atom Nuclear Lab 400
PSMA-PET/CT reporting varies widely in the U.S.
By Will Morton
Standardized interpretation frameworks for PSMA-PET/CT reporting are underused in the U.S.
October 14, 2025
2025 10 14 Incidental Findings Psma Pet Ct Thumbnail
PET/CT shows value in patients with soft-tissue sarcomas
By Will Morton
PET/CT scans can help identify which patients are most likely to benefit from treatment.
October 13, 2025
Pet Ct Scanner
SNMMI updates radioisotope production status in U.S.
By AuntMinnie.com staff writers
Projects noted in an October 10 update include IAEA's disused radium transfer program and others.
October 10, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
PSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancer
By Will Morton
Replacing F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA PET/CT can improve treatment for men with newly diagnosed prostate cancer.
October 10, 2025
2025 10 09 Jnumed Psma Pet Vs Na F Pet Thumbnail
GLP-1 drugs may confound PET/CT imaging findings
By AuntMinnie.com staff writers
The drugs are now widely prescribed for people with type 2 diabetes -- with a 700% use increase in the U.S. between 2019 and 2023.
October 7, 2025
Semaglutide Injection Pen
PSMA PET-guided radiotherapy shows promise
By Will Morton
A trial demonstrated that radiotherapy informed by PSMA-PET led to improved outcomes in prostate cancer patients.
October 3, 2025
Prostate Imaging
PET reveals mechanism underlying brain fog in long COVID
By Will Morton
Brain regions where C-11 K-2 radiotracer was increased were negatively correlated with long-COVID patients’ performance on cognitive tests.
October 2, 2025
2025 10 02 Long Covid Apar Thumbnail
SpectronRx’s Ac-225 boosted for use in Canada
By AuntMinnie.com staff writers
Ac-225 is a highly sought-after alpha-emitting isotope that shows promise for targeted cancer therapy.
October 1, 2025
Isotopes1
Page 1 of 615
Next Page